Pd(II) and Pt(II) Allyl MeO- and H-MOP
Organometallics, Vol. 24, No. 6, 2005 1313
3
H-L2), 3.71 (s, OCH3), 3.48 (d, JHH ) 4.8, Hcis-L1), 2.80 (dd,
[Pt(µ-Cl)(η3-C3H4(Me))]2 (70 mg, 0.123 mmol) was added 4 mL
of CH2Cl2, and the resulting solution was stirred for 60 min
at room temperature. After removal of the solvent, the product
was washed with 4 mL of pentane. Yield: 169 mg (91%). Anal.
Calcd for C37ClH32OPPt: C, 58.93; H, 4.28. Found: C, 58.79;
H, 4.48. 1H NMR (CD2Cl2, 500 MHz, 298 K): major isomer: δ
7.86 (3JHH ) 9.2, H-4), 7.26 (H-5), 3.80 (s, OCH3), 3.75 (bm,
Hcis-L3), 1.92 (4JHH ) 2.4, Hcis-L1), 1.88 (3JPH ) 10.1,
Htrans-L3), 1.76 (3JPtH ) 74.8, CH3-L2), 0.74 (2JPtH ) 75.4,4JHH
) 2.2, Htrans-L1). Minor isomer: δ 7.65 (3JHH ) 9.2, H-4), 6.91
(3JHH ) 9.2, H-5), 3.97 (bt, Hcis-L3), 3.58 (s, OCH3), 2.65 (m,
3JPH ) 9.4, Htrans-L3), 2.64 (Hcis-L1), 2.05 (3JPtH ) 71.7, CH3-
L2), 1.99 (Htrans-L1). 13C NMR (CD2Cl2, 125 MHz, 298 K):
major isomer: δ 155.6 (C-6), 135.0(C-2), 129.9 (C-4), 125.0 (C-
L2), 119.9 (C-1), 113.8 (C-5), 67.8 (C-L3), 55.8 (OCH3), 50.8
(C-L1), 23.4 (C(CH3)-L2). Minor isomer: δ 154.7 (C-6), 134.6
(C-2), 130.9 (C-4), 129.0 (C-3), 125.0 (C-L2), 119.3 (C-1), 112.3
(C-5), 66.9 (C-L3), 55.6 (OCH3), 49.5 (C-L1), 23.6 (C(CH3)-L2).
31P NMR (CD2Cl2, 202 MHz, 298 K): major isomer: δ 20.8 (s,
3JPH 9.9, JHH ) 14.6, Htrans-L3), 2.62 (bt, Hcis-L3), 2.37 (d,
3
)
3JHH ) 12.2, Htrans-L1), 1.18 (s, C(CH3)3, 18 H), 1.17 (s, C(CH3)3,
18 H). Minor isomer: δ 8.10 (d, 3JHH ) 9.2, H-4), 7.91 (d, 3JHH
3
3
) 9.2, H-5), 5.06 (m, H-L2), 3.86 (dd, JPH ) 10, JHH ) 14.8,
Htrans-L3), 3.79 (s, OCH3), 3.41 (d, 3JHH ) 4.9, Hcis-L1), 2.51 (d,
3JHH ) 12.3, Htrans-L1), 2.13 (bt, Hcis-L3), 1.18 (s, C(CH3)3, 18
H), 1.16 (s, C(CH3)3, 18 H). 13C NMR (CD2Cl2, 125 MHz, 223
K): major isomer: δ 155.3 (C-6), 135.0 (C-4), 133.1 (C-2), 129.4
(C-3), 124.6 (C-7), 121.8 (C-L2), 116.1 (C-5), 103.2 (C-1), 100.8
(C-L3), 57.9 (OCH3), 56.5 (C-L1), 35.4 (C(CH3)3), 31.4
(C(CH3)3). Minor isomer: δ 156.4 (C-6), 135.0 (C-4), 132.2 (C-
2), 129.1 (C-3), 124.5 (C-7), 121.5 (C-L2), 115.5 (C-5), 103.1
(C-1), 100.3 (C-L3), 58.0 (OCH3), 56.8 (C-L1), 35.4 (C(CH3)3),
31.4 (C(CH3)3). 31P NMR (CD2Cl2, 202 MHz, 223 K): major
isomer: δ 40.6 (s). Minor isomer: δ 40.2 (s). MS(ESI): 839.1
(M+ - BArF, 100%).
Synthesis of PdCl(η3-C3H5)(1b), 13. To a mixture of 1b
(100 mg, 0.151 mmol) and [Pd(µ-Cl)(η3-C3H5)]2 (27.6 mg, 0.075
mmol) was added 3 mL of CH2Cl2, and the resulting solution
was stirred for 40 min at room temperature. After removal of
the solvent, the product was washed with 4 mL of pentane.
Yield: 94 mg (74%). Anal. Calcd for C51H60PClPd: C, 72.42;
H, 7.15. Found: C, 72.32; H, 7.13. 1H NMR (CD2Cl2, 500 MHz,
253 K): major isomer: δ 7.87 (H-6), 7.83 (d, 3JHH ) 8.2, H-4),
1
1JPtP ) 4379). Minor isomer: δ 27.4 (s, JPtP ) 4364). ESI:
718.1 (M+ - Cl), 694.0, 662.0 (M+ - Cl, - C4H7), 633.0 (M+
Cl, - C4H7, - OMe), 618.0, 281.3 (M+ - MeO - MOP).
-
Synthesis of [PtCl(η3-C3H4(Me))(1b, Ar ) Ph)](BArF),
16. To a mixture of H-MOP (70 mg, 0.245 mmol) and [Pt(µ-
Cl)(η3-C3H4(Me))]2 (70 mg, 0.123 mmol) was added 4 mL of
CH2Cl2, and the resulting solution was stirred for 60 min at
room temperature. After removal of the solvent, the pale
orange product was washed with 4 mL of pentane. Yield: 158
mg (89%). Anal. Calcd for C36ClH30PPt: C, 59.71; H, 4.18.
Found: C, 60.29; H, 4.64. 1H NMR (CD2Cl2, 500 MHz, 298 K):
3
3
7.74 (d, JHH ) 8.4, H-10), 7.53 (dd, JHH ) 8.2 und 7.2, H-5),
7.24 (H-9), 6.86 (t, 3JHH ) 8.1, H-8), 6.81 (d, 3JHH ) 8.7, H-7),
4.86 (m, H-L2), 4.18 (dt, JHH ) 7.4, JPH ) 2.1, Hcis-L3), 2.86
3
3
(dd, JPH ) 10.2, JHH ) 13.3, Htrans-L3), 2.46 (d, JHH ) 6.3,
3
3
3
Hcis-L1), 1.14 (s, C(CH3)3, 18 H), 1.10 (s, C(CH3)3, 18 H), 0.99
(d, JHH ) 12.8, Htrans-L1). Minor isomer: δ 7.32 (H-5), 7.13
major isomer: δ 8.12-6.69 (aromatic), 3.82 (Hcis-L3), 2.74 (Hcis
-
3
(H-7), 4.56 (m, H-L2), 4.04 (dt, 3JHH ) 7.2, 3JPH) 1.6, Hcis-L3),
2.72 (d, 3JHH ) 6.6, Hcis-L1), 2.36 (dd, 3JPH ) 9.4, 3JHH ) 13.7,
Htrans-L3), 1.46 (d, 3JHH ) 12.0, Htrans-L1), 1.15 (s, C(CH3)3, 18
H), 1.11 (s, C(CH3)3, 18 H). 13C NMR (CD2Cl2, 125 MHz, 253
K): major isomer: δ 136.8 (C-1), 133.7 (C-2), 133.3 (C-3), 131.1
(C-6), 128.1 (C-4), 128.1 (C-10), 127.5 (C-7), 126.5 (C-5), 126.2
(C-9), 126.1 (C-8), 116.0 (C-L2), 79.0 (C-L3), 61.3 (C-L1), 35.3
L1), 2.02 (Htrans-L3), 2.01 (s, CH3-L2), 1.30 (Htrans-L1). Minor
isomer: δ 8.12-6.69 (aromatic), 3.97 (Hcis-L3), 2.47 (Htrans-L3),
2.37 (Hcis-L1), 1.89 (s, CH3-L2), 1.26 (Htrans-L1). 13C NMR (CD2-
Cl2, 125 MHz, 298 K): major isomer: δ 123.4 (C(CH3)-L2), 66.4
(C-L3), 47.9 (C-L1), 23.5 (C(CH3)-L2). Minor isomer: δ 123.8
(C(CH3)-L2), 67.1 (C-L3), 48.1 (C-L1), 23.2 (C(CH3)-L2). 31P
NMR (CD2Cl2, 202 MHz, 298 K): major isomer: δ 26.6 (s,1JPtP
) 4361). Minor isomer: δ 23.1 (s,1JPtP ) 4110). ESI: 688.1
(M+ - Cl), 632.1 (M+ - Cl, - allyl), 554,1 (M+ - Cl, - allyl, -
phenyl), 477.2 (M+ - Cl, - allyl, - 2 phenyl).
(C(CH3)3), 35.2 (C(CH3)3), 31.4 (C(CH3)3). Minor isomer:
δ
136.8 (C-1), 117.0 (C-L2), 79.2 (C-L3), 58.5 (C-L1), 35.3
(C(CH3)3), 35.2 (C(CH3)3), 31.4 (C(CH3)3). 31P NMR (CD2Cl2,
202 MHz, 253 K): major isomer: δ 18.5 (s). Minor isomer: δ
21.5 (s). MS(MALDI): 809 (M+ - Cl, 100%), 769 (M+ - C3H5
- Cl, 60%).
Synthesis of [Pt(η3-C3H4(Me))(1a, Ar ) Ph)](BArF), 17.
Complex 15 (74 mg, 0.098 mmol) and NaBArF (87 mg, 0.098
mmol) were dissolved in 4 mL of CH2Cl2, and the resulting
solution was stirred for 60 min at room temperature. The NaCl
formed was removed by filtration over Celite and the solvent
evaporated in vacuo. Yield: 130 mg (84%). Anal. Calcd for
C69H44OBF24PPt: C, 52.39; H, 2.80. Found: C, 52.19; H, 3.07.
1H NMR (CD2Cl2, 500 MHz, 298 K): major isomer: δ 8.03 (d,
3JHH ) 8.7, H-4), 7.81 (d, 3JHH ) 8.7, H-5), 6.99 (H-7), 3.48 (s,
OCH3), 3.38 (Hcis-L1), 2.22 (3JPH ) 8.3, Htrans-L3), 2.15
(Htrans-L1), 2.06 (Hcis-L3), 1.87 (3JPtH ) 71.0, CH3-L2). Minor
isomer: δ 8.06 (3JHH ) 8.8, H-4), 7.89 (3JHH ) 8.8, H-5), 3.58
Synthesis of [Pd(η3-C3H5)(1b)](BArF), 14. Complex 13
(50.0 mg, 0.059 mmol) and NaBArF (52.4 mg, 0.059 mmol)
were dissolved in 3 mL of CH2Cl2, and the resulting solution
was stirred for 30 min at room temperature. The NaCl formed
was removed by filtration over Celite and the solvent evapo-
rated in vacuo. Yield: 74.9 mg (67%). Anal. Calcd for C83H72-
BF24PPd: C, 59.57; H, 4.34. Found: C, 59.60; H, 4.60. 1H NMR
3
(CD2Cl2, 500 MHz, 273 K): major isomer: δ 8.12 (dd, JHH
)
3
6.4 and 8.9, H-5), 7.87 (H-4), 7.10 (H-7), 7.02 (d, JHH ) 6.4,
H-6), 5.70 (m, H-L2), 3.90 (bt, Hcis-L3), 3.60 (bd, JHH ) 6.4,
(s, OCH3), 3.27 (3JPH ) 8.2, Hcis-L3), 2.99 (Hcis-L1), 2.21 (Htrans
-
3
Hcis-L1), 2.76 (dd, JPH ) 9.7, JHH ) 14.8, Htrans-L3), 2.63 (d,
L1), 1.30 (Htrans-L3), 1.16 (3JPtH ) 68.0, CH3-L2). 13C NMR (CD2-
Cl2, 125 MHz, 298 K): major isomer: δ 152.2 (C-6), 137.4 (C-
2), 136.0 (C-4), 128.0 (C-3), 131.7 (C(CH3)-L2), 117.7 (C-5), 96.1
(1JPtC ) 109.2, C-1), 89.0 (C-L3), 57.2 (OCH3), 46.8 (C-L1), 23.9
(C(CH3)-L2). Minor isomer: δ 156.0 (C-6), 137.0 (C-4), 137.3
(C-2), 127.2 (C-3), 121.5 (C-L2), 116.3 (C-5), 95.8 (1JPtC ) 106.1,
C-1), 89.5 (C-L3), 57.3 (OCH3), 45.5 (C-L1), 22.7 (C(CH3)-L2).
31P NMR (CD2Cl2, 202 MHz, 298 K): major isomer: δ 40.0 (s,
3
3
3JHH ) 12.5, Htrans-L1), 1.21 (s, C(CH3)3, 36 H). Minor isomer:
3
δ 8.19 (dd, JHH ) 6.4 und 8.9, H-5), 7.86 (H-4), 7.15 (H-6),
5.01 (m, H-L2), 4.26 (dd, JPH ) 10, JHH ) 14.6, Htrans-L3),
3
3
3.48 (bd, JHH ) ca. 6.1, Hcis-L1), 3.15 (bt, Hcis-L3), 2.56 (d,
3
3JHH ) 12.5, Htrans-L1), 1.19 (s, C(CH3)3, 18 H), 1.15 (s, C(CH3)3,
18 H). 13C NMR (CD2Cl2, 125 MHz, 273 K): major isomer: δ
134.1 (C-2), 133.9 (C-3), 131.1 (C-5), 129.4 (C-4), 129.2 (C-1),
122.7 (C-L2), 107.4 (C-2), 99.3 (C-L3), 61.5 (C-L1), 35.3
(C(CH3)3), 31.3 (C(CH3)3). Minor isomer: δ 134.1 (C-2), 133.6
(C-3), 131.1 (C-5), 130.7 (C-1), 129.5 (C-4), 120.5 (C-L2), 106.4
(C-2), 100.3 (C-L3), 58.9 (C-L1), 35.3 (C(CH3)3), 31.3 (C(CH3)3),
31.2 (C(CH3)3). 31P NMR (CD2Cl2, 202 MHz, 273 K): major
isomer: δ 36.5 (s). Minor isomer: δ 36.2 (s). MS(ESI): 809.1
(M+ - BArF, 100%).
1
1JPtP ) 4093). Minor isomer: δ 40.1 (s, JPtP ) 4110). ESI:
718.1 (M+ - Cl), 694.0, 662.0 (M+ - Cl, - C4H7), 633.0 (M+
Cl, - C4H7, - OMe), 618.0.
-
Synthesis of [Pt(η3-C3H4(Me))(1b, Ar ) Ph)](BArF), 18.
[PtCl(η3-C3H4(Me))(H-MOP)], 16 (74 mg, 0.098 mmol), and
NaBArF (87 mg, 0.098 mmol) were dissolved in 4 mL of CH2-
Cl2, and the resulting solution was stirred for 60 min at room
temperature. The NaCl formed was removed by filtration and
the solvent evaporated in vacuo. Dissolving the solid in Et2O
Synthesis of [PtCl(η3-C3H4(Me))(1a, Ar ) Ph)], 15. To a
mixture of the MeO-MOP ligand (115 mg, 0.245 mmol) and